Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistDC Vapor, Inc. was cited for manufacturing and distributing e-liquid tobacco products without the required premarket authorization orders mandated by the FDA's deeming rule effective August 8, 2016. The FDA determined that e-liquids sold through the company's website were "new tobacco products" under the Family Smoking Prevention and Tobacco Control Act and therefore required marketing authorization under section 910 of the Federal Food, Drug, and Cosmetic Act before being legally marketed in the United States. The company failed to obtain the necessary premarket approval before offering these products for sale or distribution to U.S. customers.